For example, the lncRNA MYOSLID-miR-29c-3p-MCL-1 axis plays a key role in the development of GC, which provides potential new targets for diagnosis and treatment, but identification of the prognostic signature in GC is not recognised [37]. This evidence concerns the gene MYOSLID and gastric cancer.